Boosting Natural Killer Cell Therapies in Glioblastoma Multiforme Using Supramolecular Cationic Inhibitors of Heat Shock Protein 90
<jats:p>Allogeneic natural killer (aNK) cell adoptive therapy has the potential to dramatically impact clinical outcomes of glioblastoma multiforme (GBM). However, in order to exert therapeutic activity, NK cells require tumor expression of ligands for activating receptors, such as MHC Class I...
Main Authors: | Saha, Tanmoy, van Vliet, Amanda A., Cui, Chunxiao, Macias, Jorge Jimenez, Kulkarni, Arpita, Pham, Luu Nhat, Lawler, Sean, Spanholtz, Jan, Georgoudaki, Anna-Maria, Duru, Adil Doganay, Goldman, Aaron |
---|---|
Other Authors: | Massachusetts Institute of Technology. Department of Chemistry |
Format: | Article |
Published: |
Frontiers Media SA
2021
|
Online Access: | https://hdl.handle.net/1721.1/138500 |
Similar Items
-
Recent advances in the therapeutic strategies of glioblastoma multiforme
by: Aldoghachi, Asraa Faris, et al.
Published: (2022) -
Microcapsule drug delivery device for treatment of glioblastoma multiforme
by: Scott, Alexander Wesley
Published: (2010) -
Modified Swanson’s equation to detect the growth of glioblastomas multiforme (GBM) tumour
by: Mohd, Fashareena, et al.
Published: (2021) -
DNA repair capacity in multiple pathways predicts chemoresistance in glioblastoma multiforme
by: Kitange, Gaspar J., et al.
Published: (2016) -
Integration of RNA-Seq and proteomics data identifies glioblastoma multiforme surfaceome signature
by: Saiful Effendi Syafruddin, et al.
Published: (2021)